Hearing Loss, High-Frequency
4
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Communication Signage
Research Leaders
6 sponsors active, led by Cardiff and Vale University Health Board
Related Conditions
Often studied with 17 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Sight and Hearing Investigation Into Effects on Delirium
High Frequency ABR
Hybrid Cochlear Implants in Severe to Profound Adults, Children, and Adolescents
Efficacy of Hearing-aid Treatment for Patients With Tinnitus and Co-existing Hearing Loss
Research Network
Common Treatments
- Communication Signage1
- Cochlear Nucleus Hybrid S121
- Cochlear Nucleus Hybrid L241
- No Intervention1
- Hearing Aids1
Active Sponsors
- Cardiff and Vale University Health Board1
- Bruce J Gantz1
- Johns Hopkins University1
- National Institute on Aging (NIA)1
- Eye & ENT Hospital of Fudan University1
Top Investigators
Associate Professor, Departments of Medicine and Psychiatry
Eye & ENT Hospital of Fudan University
Assistant Professor, Department of Epidemiology
University of Iowa
Related Conditions
- Delirium Of Mixed Origin1
- Hearing Loss Agerelated1
- Hearing Disability1
- Hearing Loss Functional1
- Hearing Loss1